Chong Xiao

2.9k citations
24 papers · 1.1k indexed · 1 hit paper · h-index 17

Chong Xiao

24 papers receiving 1.0k citations

Hit Papers

Treatment With Lopinavir/Ritonavir or Interferon-β1b Impr...4822015202620182022100200300400

Peers

Chong Xiao
Comparison fields: 5 of 89
  • Infectious Diseases 535
  • Animal Science and Zoology 138
  • Immunology 245
  • Developmental Neuroscience 46
  • Neurology 135
Replace Jung-Eun Park with:
Jung-Eun Park South Korea
Guangliang Liu China
Sara Åkerström Sweden
Men‐Fang Shaio Taiwan
Vithiagaran Gunalan Singapore
Vinod Balasubramaniam Malaysia
Jennifer R. Tisoncik United States
Guohua Li China
Enrique Calvo Spain
Tomás Martín‐Jiménez United States
Chong Xiao relative to Jung-Eun Park South Korea Jung-Eun Park's profile →
Citations per field
00.5×10×15.3×
Jung-Eun Park · 1×
Citations per year

Countries citing papers authored by Chong Xiao

Since Specialization
Citations

This map shows the geographic impact of Chong Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Xiao more than expected).

Fields of papers citing papers by Chong Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Xiao. The network helps show where Chong Xiao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Chong Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chong Xiao Line = papers co-authored together Chong Xiao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202428
2 202316
3 201929
4
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmosetbreakdown →
2015482
5 200926
6 200930
7 200826
8 200814
9 200731
10 200716
11 200745
12 200718
13 200722
14 200620
15 200616
16 200514
17 200535
18 200528
19 200560
20 200531

About Chong Xiao

Chong Xiao is a scholar working on Agronomy and Crop Science, Behavioral Neuroscience and Developmental Neuroscience, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Animal Disease Management and Epidemiology (6 papers), Influenza Virus Research Studies (4 papers), Viral Infections and Immunology Research (4 papers), Animal Virus Infections Studies (3 papers), Asthma and respiratory diseases (3 papers), T-cell and B-cell Immunology (3 papers), Stress Responses and Cortisol (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Infectious Diseases (535 citations), Animal Science and Zoology (138 citations) and Immunology (245 citations). Chong Xiao has collaborated with scholars based in China, United States and Fiji. Frequent co-authors include Huali Jin, Youmin Kang, Chuan Qin, Wei Deng, Linlin Bao, Jian‐Piao Cai, Jasper Fuk‐Woo Chan, Hong Gao, Yanfeng Yao and Man Lung Yeung.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026